Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

[1]  R. Klausen,et al.  Selective , 2020, Encyclopedia of the UN Sustainable Development Goals.

[2]  Kristel Sleegers,et al.  Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics. , 2018, Trends in genetics : TIG.

[3]  I. Amit,et al.  Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration , 2018, Cell.

[4]  W. Nickel,et al.  Unconventional Secretion Mediates the Trans-cellular Spreading of Tau. , 2018, Cell reports.

[5]  Derek H. Oakley,et al.  Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain , 2018, Front. Neurosci..

[6]  J. Power,et al.  Evidence for newly generated interneurons in the basolateral amygdala of adult mice , 2017, Molecular Psychiatry.

[7]  D. Eisenberg,et al.  Propagation of Tau Aggregates and Neurodegeneration. , 2017, Annual review of neuroscience.

[8]  Arnab Ray Chaudhuri,et al.  The multifaceted roles of PARP1 in DNA repair and chromatin remodelling , 2017, Nature Reviews Molecular Cell Biology.

[9]  Bess Frost,et al.  A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies. , 2017, Trends in pharmacological sciences.

[10]  A. Murzin,et al.  Cryo-EM structures of Tau filaments from Alzheimer’s disease brain , 2017, Nature.

[11]  D. Knopman,et al.  Alzheimer Disease: Scientific Breakthroughs and Translational Challenges , 2017, Mayo Clinic proceedings.

[12]  J. Attems,et al.  Interactions of pathological proteins in neurodegenerative diseases , 2017, Acta Neuropathologica.

[13]  Wendy Noble,et al.  Roles of tau protein in health and disease , 2017, Acta Neuropathologica.

[14]  L. Aravind,et al.  A conserved NAD+ binding pocket that regulates protein-protein interactions during aging , 2017, Science.

[15]  S. P. Andrews,et al.  Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities , 2017, Neuron.

[16]  R. Boyapati,et al.  Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases , 2017, F1000Research.

[17]  Geoffrey M. Barrett,et al.  Tau Pathology Induces Excitatory Neuron Loss, Grid Cell Dysfunction, and Spatial Memory Deficits Reminiscent of Early Alzheimer’s Disease , 2017, Neuron.

[18]  D. Hall,et al.  C. elegans Neurons Jettison Protein Aggregates and Mitochondria Under Neurotoxic Stress , 2017, Nature.

[19]  E. Mandelkow,et al.  Additional file 5: Figure S5. of The release and trans-synaptic transmission of Tau via exosomes , 2017 .

[20]  Sandra Maday.  Mechanisms of neuronal homeostasis: Autophagy in the axon , 2016, Brain Research.

[21]  K. Zahs,et al.  Caspase-2 cleavage of tau reversibly impairs memory , 2016, Nature Medicine.

[22]  S. Correia,et al.  Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks. , 2016, Biochimica et biophysica acta.

[23]  J. Dorszewska,et al.  Molecular Basis of Familial and Sporadic Alzheimer's Disease. , 2016, Current Alzheimer research.

[24]  C. Graff,et al.  Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy , 2016, Acta neuropathologica communications.

[25]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[26]  J. Milbrandt,et al.  Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism , 2016, Neuron.

[27]  H. Arai,et al.  Characteristics of Tau and Its Ligands in PET Imaging , 2016, Biomolecules.

[28]  H. Wood.  Alzheimer disease: Evidence for trans-synaptic and exo-synaptic tau propagation in Alzheimer disease , 2015, Nature Reviews Neurology.

[29]  N. Soussi-Yanicostas,et al.  Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies? , 2015, Oxidative medicine and cellular longevity.

[30]  S. Villeda,et al.  Fat Chance for Neural Stem Cells in Alzheimer's Disease. , 2015, Cell stem cell.

[31]  Kewei Chen,et al.  Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study. , 2015, JAMA neurology.

[32]  Tobias M. Rasse,et al.  Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity. , 2015, Human molecular genetics.

[33]  M. Xue,et al.  The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease , 2015, Oxidative medicine and cellular longevity.

[34]  H. Brown,et al.  Microarray analysis of the in vivo response of microglia to Aβ peptides in mice with conditional deletion of the prostaglandin EP2 receptor , 2015, Genomics data.

[35]  F. Coppedè,et al.  DNA damage in neurodegenerative diseases. , 2015, Mutation research.

[36]  Pierre J. Magistretti,et al.  A Cellular Perspective on Brain Energy Metabolism and Functional Imaging , 2015, Neuron.

[37]  L. Blanchoin,et al.  Tau co-organizes dynamic microtubule and actin networks , 2015, Scientific Reports.

[38]  M. Breakspear,et al.  The connectomics of brain disorders , 2015, Nature Reviews Neuroscience.

[39]  David C Rowland,et al.  Place cells, grid cells, and memory. , 2015, Cold Spring Harbor perspectives in biology.

[40]  J. Trojanowski,et al.  Spreading of pathology in neurodegenerative diseases: a focus on human studies , 2015, Nature Reviews Neuroscience.

[41]  John M. Beggs,et al.  Functional Clusters, Hubs, and Communities in the Cortical Microconnectome , 2014, Cerebral cortex.

[42]  D. Rubinsztein,et al.  Autophagy and neurodegeneration. , 2012, The Journal of clinical investigation.

[43]  T. Arendt,et al.  Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer’s disease pathology , 2015, Journal of Neural Transmission.

[44]  P. Szekeres,et al.  Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates , 2014, The Journal of Biological Chemistry.

[45]  Teng Jiang,et al.  Prion-like Mechanisms in Alzheimer's Disease. , 2014, Current Alzheimer research.

[46]  Xinglong Wang,et al.  Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. , 2014, Biochimica et biophysica acta.

[47]  S. Sollott,et al.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. , 2014, Physiological reviews.

[48]  L. Grinberg,et al.  Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies , 2014, Neuron.

[49]  R. Mostoslavsky,et al.  Sirtuins, metabolism, and DNA repair. , 2014, Current opinion in genetics & development.

[50]  J. Gilley,et al.  Wallerian degeneration: an emerging axon death pathway linking injury and disease , 2014 .

[51]  P. Rabinovitch,et al.  Mitochondrial oxidative stress in aging and healthspan , 2014, Longevity & healthspan.

[52]  L. Buée,et al.  A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions , 2014, Front. Cell. Neurosci..

[53]  J. Sontag,et al.  Protein phosphatase 2A dysfunction in Alzheimer’s disease , 2014, Front. Mol. Neurosci..

[54]  D. Holtzman,et al.  Neuronal activity regulates extracellular tau in vivo , 2014, The Journal of experimental medicine.

[55]  A. Mietelska-Porowska,et al.  Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction , 2014, International journal of molecular sciences.

[56]  F. Austin,et al.  Lactococcosis in Silver Carp. , 2014, Journal of aquatic animal health.

[57]  M. Hemberg,et al.  Tau promotes neurodegeneration through global chromatin relaxation , 2014, Nature Neuroscience.

[58]  Casey Cook,et al.  Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance , 2013, Human molecular genetics.

[59]  Thomas Arendt,et al.  Neuronal plasticity in hibernation and the proposed role of the microtubule-associated protein tau as a "master switch" regulating synaptic gain in neuronal networks. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[60]  R. Nixon,et al.  The role of autophagy in neurodegenerative disease , 2013, Nature Medicine.

[61]  Dan-shen Zhang,et al.  Oxidative stress, mitochondrial damage and neurodegenerative diseases , 2013, Neural regeneration research.

[62]  A. Chiang,et al.  Loss of vesicular dopamine release precedes tauopathy in degenerative dopaminergic neurons in a Drosophila model expressing human tau , 2013, Acta Neuropathologica.

[63]  Wendy Noble,et al.  Physiological release of endogenous tau is stimulated by neuronal activity , 2013, EMBO reports.

[64]  E. Huang,et al.  Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation , 2013, Acta Neuropathologica.

[65]  A. Reyes,et al.  Human mitochondrial DNA replication. , 2012, Cold Spring Harbor perspectives in biology.

[66]  B. Hyman,et al.  Propagation of Tau Pathology in a Model of Early Alzheimer’s Disease , 2012, Neuron.

[67]  D. Attwell,et al.  Synaptic Energy Use and Supply , 2012, Neuron.

[68]  M. Beal,et al.  Mitochondrial Dysfunction in Neurodegenerative Diseases , 2012, Journal of Pharmacology and Experimental Therapeutics.

[69]  M. Goedert,et al.  Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy , 2012, Autophagy.

[70]  H. Möller,et al.  [Structural and functional neuronal connectivity in Alzheimer's disease: a combined DTI and fMRI study]. , 2012, Der Nervenarzt.

[71]  S. Hébert,et al.  Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors , 2012, Scientific Reports.

[72]  D. Řípová,et al.  Structure and Pathology of Tau Protein in Alzheimer Disease , 2012, International journal of Alzheimer's disease.

[73]  Jason E Gestwicki,et al.  Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo , 2012, Autophagy.

[74]  E. Mandelkow,et al.  Interaction of tau protein with model lipid membranes induces tau structural compaction and membrane disruption. , 2012, Biochemistry.

[75]  Naruhiko Sahara,et al.  Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.

[76]  Blaine R. Roberts,et al.  Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.

[77]  M. Gallagher,et al.  Episodic Memory on the Path to Alzheimer's Disease This Review Comes from a Themed Issue on Neurobiology of Disease Edited , 2022 .

[78]  A. McKee,et al.  Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[79]  Dietmar R. Thal,et al.  Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years , 2011, Journal of neuropathology and experimental neurology.

[80]  Pico Caroni,et al.  Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration , 2011, Neuron.

[81]  Ralph A. Nixon,et al.  Autophagy failure in Alzheimer's disease—locating the primary defect , 2011, Neurobiology of Disease.

[82]  David Eisenberg,et al.  Towards a Pharmacophore for Amyloid , 2011, PLoS biology.

[83]  Meaghan Morris,et al.  The Many Faces of Tau , 2011, Neuron.

[84]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[85]  J. Trojanowski,et al.  The acetylation of tau inhibits its function and promotes pathological tau aggregation. , 2011, Nature communications.

[86]  F. Terro,et al.  Post-translational modifications of tau protein: Implications for Alzheimer's disease , 2011, Neurochemistry International.

[87]  G. Jackson,et al.  Drosophila models of neurodegenerative disease , 2005, NeuroRX.

[88]  L. Buée,et al.  Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.

[89]  Fei Liu,et al.  Tau in Alzheimer disease and related tauopathies. , 2010, Current Alzheimer research.

[90]  V. Haroutunian,et al.  Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.

[91]  Y. Jho,et al.  Monte carlo simulations of tau proteins: effect of phosphorylation. , 2010, Biophysical Journal.

[92]  V. Haroutunian,et al.  Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.

[93]  D. Wilcock,et al.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.

[94]  M. Freeman,et al.  Wallerian degeneration, wld(s), and nmnat. , 2010, Annual review of neuroscience.

[95]  M. Blackledge,et al.  Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules. , 2009, Biochemistry.

[96]  Keiji Tanaka,et al.  The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. , 2009, Biochimica et biophysica acta.

[97]  M. Wolfe.  Tau Mutations in Neurodegenerative Diseases* , 2009, Journal of Biological Chemistry.

[98]  J. Lucas,et al.  Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options , 2009, European journal of neurology.

[99]  I. Grundke‐Iqbal,et al.  Mechanisms of tau-induced neurodegeneration , 2009, Acta Neuropathologica.

[100]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[101]  S. Strittmatter,et al.  Axon regeneration in the peripheral and central nervous systems. , 2009, Results and problems in cell differentiation.

[102]  Mandana Amiri,et al.  Mitochondrial biogenesis in the axons of vertebrate peripheral neurons , 2008, Developmental neurobiology.

[103]  O. Sporns,et al.  Mapping the Structural Core of Human Cerebral Cortex , 2008, PLoS biology.

[104]  C. Lyketsos,et al.  Mild cognitive impairment: searching for the prodrome of Alzheimer's disease , 2008, World psychiatry : official journal of the World Psychiatric Association.

[105]  George Perry,et al.  Physiological regulation of tau phosphorylation during hibernation , 2008, Journal of neurochemistry.

[106]  Mark A. Smith,et al.  Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease , 2008, International journal of experimental pathology.

[107]  I. Grundke‐Iqbal,et al.  Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease , 2008, FEBS letters.

[108]  J. Ávila.  Tau kinases and phosphatases , 2007, Journal of cellular and molecular medicine.

[109]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[110]  B. Winckler.  BDNF Instructs the Kinase LKB1 To Grow an Axon , 2007, Cell.

[111]  Tudor A. Fulga,et al.  Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo , 2007, Nature Cell Biology.

[112]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[113]  Craig C Garner,et al.  Synaptic Protein Dynamics in Hibernation , 2007, The Journal of Neuroscience.

[114]  D. Geschwind,et al.  Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro. , 2006, Biochemistry.

[115]  E. Holzbaur,et al.  Axonal transport and neurodegenerative disease. , 2006, Biochimica et biophysica acta.

[116]  D. Williams,et al.  Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule‐associated protein tau , 2006, Internal medicine journal.

[117]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[118]  L. Loeb,et al.  The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[119]  Olaf Sporns,et al.  The Human Connectome: A Structural Description of the Human Brain , 2005, PLoS Comput. Biol..

[120]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[121]  N. Shahani,et al.  Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. , 2005, Biochimica et biophysica acta.

[122]  Michel Goedert,et al.  Mutations causing neurodegenerative tauopathies. , 2005, Biochimica et biophysica acta.

[123]  John Q Trojanowski,et al.  Transgenic animal models of tauopathies. , 2005, Biochimica et biophysica acta.

[124]  J. O’Keefe,et al.  Dual phase and rate coding in hippocampal place cells: Theoretical significance and relationship to entorhinal grid cells , 2005, Hippocampus.

[125]  F. Liu,et al.  Post-translational modifications of tau protein in Alzheimer’s disease , 2005, Journal of Neural Transmission.

[126]  Daniel J. Klionsky,et al.  Autophagy in Health and Disease: A Double-Edged Sword , 2004, Science.

[127]  C. Cotman,et al.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. , 2004, The Journal of clinical investigation.

[128]  H. Braak,et al.  Alzheimer's disease affects limbic nuclei of the thalamus , 2004, Acta Neuropathologica.

[129]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[130]  Michel Goedert,et al.  Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[131]  J. Goldberg.  How does an axon grow? , 2003, Genes & development.

[132]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[133]  D. Geschwind,et al.  Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila , 2002, Neuron.

[134]  V. Muñoz,et al.  Alpha-helix structure in Alzheimer's disease aggregates of tau-protein. , 2002, Biochemistry.

[135]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[136]  R. Crowther,et al.  Abnormal tau-containing filaments in neurodegenerative diseases. , 2000, Journal of structural biology.

[137]  J. Morris,et al.  Tau polymorphisms are not associated with Alzheimer's disease , 2000, Neuroscience Letters.

[138]  Barbara Shukitt-Hale,et al.  Reversals of Age-Related Declines in Neuronal Signal Transduction, Cognitive, and Motor Behavioral Deficits with Blueberry, Spinach, or Strawberry Dietary Supplementation , 1999, The Journal of Neuroscience.

[139]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[140]  H. Band,et al.  Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.

[141]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[142]  N. Cairns,et al.  An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease , 1997, Journal of neurochemistry.

[143]  B. Van Houten,et al.  Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[144]  R. Brandt,et al.  Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain , 1995, The Journal of cell biology.

[145]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[146]  N. Hirokawa,et al.  Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons , 1992, Nature.

[147]  R. Crowther.  Straight and paired helical filaments in Alzheimer disease have a common structural unit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[148]  R. Crowther,et al.  Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.

[149]  L. Hood,et al.  Purification and structural studies of a major scrapie prion protein , 1984, Cell.

[150]  M. Kirschner,et al.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.

[151]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[152]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .